跳至主要内容
临床试验/CTRI/2024/08/072046
CTRI/2024/08/072046尚未招募2 期

A comparative clinical study between polyherbal combination (Guduchi, Guggulu, Manjistha) and xanthine oxidase inhibitor in the management of Vatarakta w.s.r to hyperuricemia - NI

Government of West Bengal0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patient having classical signs and symptoms of Vatarakta mentioned in Ayurvedic text like Ruk(pain), Toda (pricking pain), Sparsha asahatva(tenderness), Shopha (swelling), Raga(redness), Daha (burning sensation) and Stabdhata(stiffness) of sandhis of pada and hasta
  • 2.Serum uric acid level
  • IN Female- more than 6mg/dl but less or equal 9mg/dl
  • IN Male -more than 7mg/dl but less or equal 10mg/dl
  • 3.Patients who agreed to follow the study protocol and give constant for clinical trial.

排除标准

  • 1.Patients suffering from diabetes mellitus and uncontrolled hypertension,malignant disorders, genetic disorders, renal disorders.
  • 2.Any other inflammatory joint disorders like rheumatoid arthritis, tubercular arthritis, septic arthritis, psoriatic arthritis
  • 3.Patients having deposition of monosodium urate monohydrate crystals in joints or having tophi.
  • 4.Pregnant woman and lactating mother suffering from arthritis.
  • 5.Severe deformity and ankylosing of the joints.
  • 6.Patients who are not willing to come under trial or give consent.

研究者

相似试验